Voyager Therapeutics, Inc. is a clinical-stage gene therapy company developing gene therapies for severe diseases of the central nervous system. Their founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA interference and neuroscience.
Voyager Therapeutics, Inc.
Industry: Health Care – Biotechnology: Biological Products (No Diagnostic Substances)
Stock Symbol: VYGR – NASDAQ
Animal Usage: Animal Testing
Our Opinion
Voyager Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their clinical therapies.
Company Description
Contact: http://voyagertherapeutics.com , sarah@sternir.com